Association of neutrophil-to-lymphocyte and lymphocyte-to-monocyte ratios with treatment response and quality of life in colorectal and pancreatic cancer: A prospective analysis
References
- Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31-46. DOI: 10.1158/2159-8290.CD-21-1059
- Diakos CI, Charles KA, McMillan DC, Clarke SJ. Cancer-related inflammation and treatment effectiveness. Lancet Oncol. 2014;15(11):e493-e503. DOI: 10.1016/S1470-2045(14)70263-3
- Liu K, Tang S, Liu C, et al. Systemic immune-inflammatory biomarkers linked to non-alcoholic fatty liver disease risk. Front Immunol. 2024;15. DOI: 10.3389/fimmu.2024.1337241
- Nassar FJ, Talhouk R, Zgheib N, et al. MicroRNA: A signature for colorectal cancer progression and response to treatment. Front Immunol. 2022;13.
- Forget P, Khalifa C, Defour JP, et al. What is the normal value of the neutrophil-to-lymphocyte ratio? BMC Res Notes. 2017;10:12. DOI: 10.1186/s13104-016-2335-5
- Li W, Tang Y, Song Y, et al. Prognostic role of pretreatment plasma D-dimer in patients with solid tumors: A systematic review and meta-analysis. Cell Physiol Biochem. 2018;45(4):1663-1676. DOI: 10.1159/000487734
- Cao YD, Sun HW, Li TC, et al. Validated nomograms for nonmetastatic colorectal cancer prognosis prediction: a population-based study. Front Oncol. 2025 Oct 24;15:1691693. DOI: 10.3389/fonc.2025.1691693
- Reddy AV, Hill CS, Sehgal S, et al. High neutrophil-to-lymphocyte ratio following stereotactic body radiation therapy is associated with poor clinical outcomes in pancreatic cancer. J Gastrointest Oncol. 2022;13:368-379. DOI: 10.21037/jgo-21-513
- Templeton AJ, McNamara MG, Šeruga B, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014;106(6):dju124. DOI: 10.1093/jnci/dju124
- Shusterman M, Jou E, Kaubisch A, et al. The neutrophil-tolymphocyte ratio is a prognostic biomarker in an ethnically diverse patient population with advanced pancreatic cancer. J Gastrointest Cancer. 2020;51:868-876. DOI: 10.1007/s12029-019-00316-8
- Coffelt SB, Wellenstein MD, de Visser KE. Neutrophils in cancer: neutral no more. Nat Rev Cancer. 2016;16(7):431-446. DOI: 10.1038/nrc.2016.52
- Song W, Wang K, Zhang R, et al. Prognostic value of the lymphocyte-monocyte ratio in pancreatic cancer: A meta-analysis. Medicine. 2023;100(40):e27464.
- Lin S, Fang Y, Mo Z, et al. Prognostic value of lymphocyte-tomonocyte ratio in pancreatic cancer: A systematic review. World J Surg Oncol. 2020;18:186. DOI: 10.1186/s12957-020-01962-0
- Stotz M, Gerger A, Eisner F, et al. Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer. 2013;109(2):416-21. DOI: 10.1038/bjc.2013.332
- Mantovani A, Marchesi F, Malesci A, et al. Tumour-associated macrophages as treatment targets in oncology. Nat Rev Clin Oncol. 2017;14(7):399-416. DOI: 10.1038/nrclinonc.2016.217
- Facciorusso A, Del Prete V, Antonino M, et al. Serum ferritin as a new prognostic factor in hepatocellular carcinoma patients treated with radiofrequency ablation. J Gastroenterol Hepatol. 2014;29(11):1905-10. DOI: 10.1111/jgh.12618
- Lee S, Song A, Park YS, et al. Prognostic value of preoperative serum ferritin in colorectal cancer. Ann Coloproctol. 2021;37(4):223.
- Ay C, Dunkler D, Pirker R, et al. High D-dimer levels are associated with poor prognosis in cancer patients. Haematologica. 2012;97(8):1158-64. DOI: 10.3324/haematol.2011.054718
- Wang J, Li J, Wei S, et al. The ratio of platelets to lymphocytes predicts the prognosis of metastatic colorectal cancer. Gastroenterol Res Pract. 2021;9699499. DOI: 10.1155/2021/9699499
- Tang F, Dai P, Wei Q, et al. The neutrophil-to-monocyte ratio and platelet-to-white blood cell ratio represent novel prognostic markers. Gastroenterol Res Pract. 2021;6693028. DOI: 10.1155/2021/6693028
- Pine JK, Morris E, Hutchins GG, et al. Systemic neutrophil-tolymphocyte ratio in colorectal cancer: the relationship to patient survival, tumour biology and local lymphocytic response to tumour. Br J Cancer. 2015;113(2):204-11. DOI: 10.1038/bjc.2015.87
- Laird BJ, McMillan DC, Fayers P, et al. The systemic inflammatory response and its relationship to pain and other symptoms in advanced cancer. Oncologist. 2013;18(9):1050-5. DOI: 10.1634/theoncologist.2013-0120
- McMillan DC. The systemic inflammation-based Glasgow Prognostic Score: a decade of experience in patients with cancer. Cancer Treat Rev. 2013;39(5):534-40. DOI: 10.1016/j.ctrv.2012.08.003
Language: English
Page range: 151 - 156
Submitted on: Sep 17, 2025
Accepted on: Feb 13, 2026
Published on: Apr 24, 2026
Published by: Romanian Association of Laboratory Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2026 Kalin Papochiev, Petar Trifonov, Irena Ivanova, Petya Milanova-Krasteva, Vladimir Goranov, Zahariy Krastev, published by Romanian Association of Laboratory Medicine
This work is licensed under the Creative Commons Attribution 4.0 License.